Rosicon G 2mg/1mg Tablet
By Rosicon G
Rx
10 Tablet in a Strip

Composition
Rosiglitazone(2mg) + Glimepiride(1mg)

Manufacturer - Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.

Expires on or after
September, 2025

liver
When taking Rosicon G 2mg/1mg Tablet, it is important to be cautious if you have liver disease. It may be necessary to adjust the dose of the medication, so it is advised to consult your doctor before starting treatment. Patients with severe liver disease are not recommended to use Rosicon G 2mg/1mg Tablet due to the risk of experiencing very low blood sugar levels. However, it is noted that these levels may return to normal over an extended period. Please ensure to seek medical advice and supervision when considering this medication for liver-related issues.

kidney
Rosicon G 2mg/1mg Tablet needs caution for patients with kidney disease. Dose adjustment may be necessary, and the use is not recommended for severe kidney disease due to potential low blood sugar levels. Consult your doctor for guidance.

alcohol
Consult your doctor when consuming alcohol with Rosicon G 2mg/1mg Tablet.

driving
It is important to note that your driving ability can be impacted if your blood sugar levels are too low or too high. If you experience these symptoms, avoid driving when taking Rosicon G 2mg/1mg Tablet.

pregnancy
Rosicon G 2mg/1mg Tablet may be unsafe during pregnancy. Limited human studies show risks to the developing baby. Animal studies also indicate harmful effects. Your doctor will assess benefits and risks before prescribing. Consult your doctor for guidance.

breastfeeding
It is better to consult your doctor before using Rosicon G 2mg/1mg Tablet.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹62.5
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024